Influenza virus vaccine (Fluviral)
Sponsors
ID Biomedical Corporation, Quebec
Conditions
Influenza
Phase 3
Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.
NCT00216242
Start: 2005-09-30End: 2007-05-31Target: 7400Updated: 2006-12-11
Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over
CompletedNCT00232947
Start: 2005-10-31End: 2006-02-28Target: 900Updated: 2007-01-22